Erratum: Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-derived Xenograft Mouse Model

Samenvatting

An erratum was issued for: Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-derived Xenograft Mouse Model. The Authors section was updated.

Samenvatting

An erratum was issued for: Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-derived Xenograft Mouse Model. The Authors section was updated from:

Claudia Manriquez Roman^1,2,3,4,5
R. Leo Sakemura^1,2
Fang Jin⁶
Roman H. Khadka⁶
Mohamad M. Adada^1,2
Elizabeth L. Siegler^1,2
Aaron J. Johnson⁶
Saad S. Kenderian^1,2,6
1T Cell Engineering Laboratory, Mayo Clinic, Rochester,
²Division of Hematology, Mayo Clinic, Rochester,
³Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester,
⁴Department of Molecular Medicine, Mayo Clinic, Rochester,
⁵Regenerative Sciences PhD Program, Mayo Clinic, Rochester,
⁶Department of Immunology, Mayo Clinic, Rochester

to:

Claudia Manriquez Roman^1,2,3,4,5
R. Leo Sakemura^1,2
Brooke L. Kimball^1,2
Fang Jin⁶
Roman H. Khadka⁶
Mohamad M. Adada^1,2
Elizabeth L. Siegler^1,2
Aaron J. Johnson⁶
Saad S. Kenderian^1,2,6
1T Cell Engineering Laboratory, Mayo Clinic, Rochester,
²Division of Hematology, Mayo Clinic, Rochester,
³Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester,
⁴Department of Molecular Medicine, Mayo Clinic, Rochester,
⁵Regenerative Sciences PhD Program, Mayo Clinic, Rochester,
⁶Department of Immunology, Mayo Clinic, Rochester

Protocol

An erratum was issued for: Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-derived Xenograft Mouse Model. The Authors section was updated from:

Claudia Manriquez Roman^1,2,3,4,5
R. Leo Sakemura^1,2
Fang Jin⁶
Roman H. Khadka⁶
Mohamad M. Adada^1,2
Elizabeth L. Siegler^1,2
Aaron J. Johnson⁶
Saad S. Kenderian^1,2,6
1T Cell Engineering Laboratory, Mayo Clinic, Rochester,
²Division of Hematology, Mayo Clinic, Rochester,
³Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester,
⁴Department of Molecular Medicine, Mayo Clinic, Rochester,
⁵Regenerative Sciences PhD Program, Mayo Clinic, Rochester,
⁶Department of Immunology, Mayo Clinic, Rochester

to:

Claudia Manriquez Roman^1,2,3,4,5
R. Leo Sakemura^1,2
Brooke L. Kimball^1,2
Fang Jin⁶
Roman H. Khadka⁶
Mohamad M. Adada^1,2
Elizabeth L. Siegler^1,2
Aaron J. Johnson⁶
Saad S. Kenderian^1,2,6
1T Cell Engineering Laboratory, Mayo Clinic, Rochester,
²Division of Hematology, Mayo Clinic, Rochester,
³Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester,
⁴Department of Molecular Medicine, Mayo Clinic, Rochester,
⁵Regenerative Sciences PhD Program, Mayo Clinic, Rochester,
⁶Department of Immunology, Mayo Clinic, Rochester